|
|
|
|
|
| Available: 0 |
| List Price:$185.00 |
|
Other formats:
|
| Edition: | 1st |
| Publisher: | Academic Press, Incorporated |
| ISBN: | 0-12-072651-3 (0120726513) |
| ISBN-13: | 978-0-12-072651-6 (9780120726516) |
| Binding: | Hardcover |
| Copyright: | 2002 |
| Publish Date: | 10/01 |
| Weight: | 2.61 Lbs. |
| Pages: | 397 |
| Carton Quantity: | 16 |
| Subject Class: | ONC (Oncology) |
| Return Policy: | Returns accepted up to 90 days provided no other recalls or return restrictions apply. |
| Table Of Contents: |
View
|
| Contributing Authors: |
View
|
| ProQuest Ebook Central: |
Available in ProQuest Ebook Central™ View
|
|
|
| |
| Discipline: | Pharmacology | | Subject Definition: | Antineoplastic Agents; Drug Eval, Preclinical | | NLM Class: | QV 269 | | LC Class: | RC268 | | Abstract: | One of the essential goals in medicine today is to devise therapies leading to the cure or effective control of cancer. This multidisciplinary process includes the identification of new therapeutic targets, drug design, and synthesis, preclinical testing, and clinical trials. Most scientists and clinicians concerned with anticancer drugs are familiar with only parts of this process. This book provides the best of science and clinical application in a single reference work. |
|
| |
|
Related and Ancillary Products:
|
|
|
|
|
|
|
Follow Matthews Book Co. on:
Copyright © 2001-2026 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews